Karina Cordoba Mena
Clínical Research Bacteriology at CENTRO DE ESTUDIOS EN INFECTOLOGIA PEDIATRICA- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
PROGRAMA REACTIVOVIGILANCIA
Invima ColombiaJul, 2023- Oct, 2024 -
Separación de células mononucleares PBMC's por gradiente de FICOLL.
CIDEIMJul, 2023- Oct, 2024 -
INTRODUCTION TO CLINICAL RESEARCH
The Global Health NetworkMar, 2023- Oct, 2024 -
STANDARDS OF GOOD CLINICAL PRACTICE ICH E6 (R2)
The Global Health NetworkMar, 2023- Oct, 2024 -
XVII INTERNATIONAL CONGRESS OF PEDIATRIC INFECTOLOGY
CENTRO DE ESTUDIOS EN INFECTOLOGIA PEDIATRICADec, 2022- Oct, 2024 -
GOOD CLINICAL PRACTICE COURSE - E6 (Revision 2)
AVANZAR ColombiaSep, 2020- Oct, 2024 -
TRANSPORTING DANGEROUS GOODS TRAINING
Mayo ClinicMar, 2023- Oct, 2024 -
GOOD CLINICAL PRACTICES AND NATIONAL REGULATION ON CLINICAL RESEARCH
Investigación y Extensión, Universidad Nacional de Colombia, sede BogotáNov, 2021- Oct, 2024 -
CURSO EXPEDIDOR ESPECIFICO EN MERCANCIAS PELIGROSAS
AviancaApr, 2022- Oct, 2024 -
GOOD CLINICAL PRACTICE
NIDA Clinical Trials NetworkSep, 2020- Oct, 2024
Experience
-
CENTRO DE ESTUDIOS EN INFECTOLOGIA PEDIATRICA
-
Colombia
-
Research Services
-
1 - 100 Employee
-
Clínical Research Bacteriology
-
Sep 2020 - Present
- I am currently the lead bacteriologist for the NOR-212 protocol, which evaluates the efficacy, safety, and immunogenicity of the HIL-214 intramuscular norovirus vaccine. - I am a lead bacteriology in multiple research protocols related to vaccines, among the most prominent, dengue vaccine (Takeda) and covid 19 (Janssen). - I work hand in hand with diferrent international pharmaceutical companies, thus following the provisions of the dufferent laboratory manuals. - I am currently the lead bacteriologist for the NOR-212 protocol, which evaluates the efficacy, safety, and immunogenicity of the HIL-214 intramuscular norovirus vaccine. - I am a lead bacteriology in multiple research protocols related to vaccines, among the most prominent, dengue vaccine (Takeda) and covid 19 (Janssen). - I work hand in hand with diferrent international pharmaceutical companies, thus following the provisions of the dufferent laboratory manuals.
-
-
-
HOSPITAL LA BUENA ESPERANZA DE YUMBO
-
1 - 100 Employee
-
Bacteriologa
-
Jan 2019 - Feb 2021
- Participant in the external evaluation carried out by the departmental laboratory of public health on tuberculosis, which obtained a score of 95%. - Help patients with their daily needs, which caused positive feedback to the clinical laboratory area. - Participant in the external evaluation carried out by the departmental laboratory of public health on tuberculosis, which obtained a score of 95%. - Help patients with their daily needs, which caused positive feedback to the clinical laboratory area.
-
-
-
CENTRO MEDICO VICENTE DE PAUL
-
Bogotá, Distrito Capital, Colombia
-
Bacteriologa
-
Mar 2018 - May 2018
-
-
-
HOSPITAL LOCAL ISMAEL ROLDAN VALENCIA
-
Quibdó, Chocó, Colombia
-
Bacteriologa
-
Nov 2016 - Dec 2017
-
-
Education
-
Pontificia Universidad Javeriana
Diplomado en Medicina transfusional e inmunohematología, Facultad de ciencias -
Corporación Universitaria Rafael Núñez
Bacteriologo, Microbiología médica y bacteriología